(Mary Ann Liebert, Inc./Genetic Engineering News) Researchers around the globe are working on turning microRNAs, over 5,000 of which already have been identified, into novel drugs for a wide range of applications, reports Genetic Engineering & Biotechnology News. These noncoding single-stranded RNAs act through binding to complementary mRNA sequences, thus preventing their translation into protein or accelerating mRNA breakdown, according to the March 15 issue of GEN.
Read »GEN reports on therapeutic potential of microRNA
http://www.eurekalert.org –
Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Engineering
- NASA sees a 'hot tower' in newborn eastern Pacific Tropical Depression 2E
- $3.3 million NSF award creates UCSB and UTEP partnership for materials science and engineering research
- NASA satellite sees Tropical Storm Sanvu pass Guam, strengthen
- Internet politics, policies have rapidly become integral to US international affairs
- A non-invasive intracellular 'thermometer' with fluorescent proteins has been created